Literature DB >> 15548229

Fast onset of dopamine uptake inhibition by intravenous cocaine.

Yolanda Mateo1, Evgeny A Budygin, Drake Morgan, David C S Roberts, Sara R Jones.   

Abstract

In vivo voltammetry in the nucleus accumbens of anesthetized rats was used to investigate the time of onset of dopamine uptake inhibition by intravenous cocaine. There is disagreement between behavioral and neurochemical studies concerning the time-course of cocaine effects. Because of the high temporal resolution of voltammetry, the processes of dopamine release and uptake could be temporally separated to make evaluation of cocaine effects on uptake easier to address. Within 4 s after intravenous cocaine administration (1.5 mg/kg) there was significant inhibition of dopamine uptake that reached a plateau in 20 s. The peak heights of electrically evoked dopamine signals were also rapidly increased by cocaine. The signals returned to baseline values within approximately 1 h. In parallel behavioral studies, locomotor activity was significantly increased within 5-6 s following intravenous infusion of cocaine. Here we demonstrate that intravenous cocaine administration begins inhibiting the uptake of dopamine within a few seconds. This is at least 10-fold faster than previous neurochemical estimates. The present findings may contribute to the understanding of the neurobiological mechanisms underlying the early behavioral responses to cocaine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15548229     DOI: 10.1111/j.1460-9568.2004.03736.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  29 in total

1.  Differentiating the rapid actions of cocaine.

Authors:  Roy A Wise; Eugene A Kiyatkin
Journal:  Nat Rev Neurosci       Date:  2011-06-02       Impact factor: 34.870

2.  The regional specificity of rapid actions of cocaine.

Authors:  Brandon J Aragona
Journal:  Nat Rev Neurosci       Date:  2011-10-05       Impact factor: 34.870

3.  The role of peripheral and central sodium channels in mediating brain temperature fluctuations induced by intravenous cocaine.

Authors:  Eugene A Kiyatkin; P Leon Brown
Journal:  Brain Res       Date:  2006-09-07       Impact factor: 3.252

4.  Differential regulation of accumbal dopamine transmission in rats following cocaine, heroin and speedball self-administration.

Authors:  Lindsey P Pattison; Scot McIntosh; Evgeny A Budygin; Scott E Hemby
Journal:  J Neurochem       Date:  2012-05-23       Impact factor: 5.372

Review 5.  Examining the complex regulation and drug-induced plasticity of dopamine release and uptake using voltammetry in brain slices.

Authors:  Mark J Ferris; Erin S Calipari; Jordan T Yorgason; Sara R Jones
Journal:  ACS Chem Neurosci       Date:  2013-05-06       Impact factor: 4.418

6.  Learning that a cocaine reward is smaller than expected: A test of Redish's computational model of addiction.

Authors:  Katherine R Marks; David N Kearns; Chesley J Christensen; Alan Silberberg; Stanley J Weiss
Journal:  Behav Brain Res       Date:  2010-04-08       Impact factor: 3.332

7.  Real-time measurement of dopamine fluctuations after cocaine in the brain of behaving rats.

Authors:  Michael L A V Heien; Amina S Khan; Jennifer L Ariansen; Joseph F Cheer; Paul E M Phillips; Kate M Wassum; R Mark Wightman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

Review 8.  Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.

Authors:  Satoshi Ikemoto
Journal:  Brain Res Rev       Date:  2007-05-17

9.  Dopamine uptake inhibition is positively correlated with cocaine-induced stereotyped behavior.

Authors:  Evgeny A Budygin
Journal:  Neurosci Lett       Date:  2007-10-11       Impact factor: 3.046

10.  Behavioral economic assessment of price and cocaine consumption following self-administration histories that produce escalation of either final ratios or intake.

Authors:  Erik B Oleson; David C S Roberts
Journal:  Neuropsychopharmacology       Date:  2008-10-29       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.